Recall Register

Food, drugs, devices › Diagnostica Stago, Inc.

Device recall: STA R Max fully automatic clinical instrument designed to perform tests on human plasmas, Reference Numbers 59013 and 59

FDA enforcement event 92007 · Class II · initiated 22 Mar 2023 · status Ongoing

DeviceVoluntary: Firm initiated3 product recordsParsippany, NJ

FDA enforcement event 92007 is a device recall by Diagnostica Stago, Inc. of Parsippany, NJ, initiated 22 Mar 2023 and classified Class II, with 3 product records.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 88% of the 917 device enforcement events initiated in 2023 carry the same class.

Status: Ongoing. Initiation: voluntary: firm initiated. Diagnostica Stago, Inc. has 16 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Diagnostica Stago, Inc., Parsippany, NJ.

Reason for recall

"An internal investigation identified a bug in this firmware version, resulting in the following:Intermittent shortened coagulation times and an increased frequency of occurrence of a technical error reported by the analyzer (error 13)."

Distribution

"US Nationwide distribution in the states of IL, MA, MN, NE, TX, and WI."

Product records

Recall numberProductQuantityClassStatusReport date
Z-1575-2023STA R Max fully automatic clinical instrument designed to perform tests on human plasmas, Reference Numbers 59013 and 590266 analyzersClass IIOngoing17 May 2023
Z-1576-2023STA Compact Automated Multi-Parametric Analyzer, Reference Numbers 58602 and 586122 analyersClass IIOngoing17 May 2023
Z-1577-2023STA Compact Max fully automatic clinical analyzer, Reference Numbers 58602 and 586125 analyzersClass IIOngoing17 May 2023

Context

88%of 2023 device events are Class II917 events that year
3product records in this eventfirm median: 1
16events on this register for the firm

Other enforcement events for Diagnostica Stago, Inc.

InitiatedProduct (first record)TypeClassRecords
29 Jul 2026STA Staclot Protein S, Model/Catalog Number: 00746-Reagent Lot number 273074; qualitative and quantitative factor deficiDeviceClass II1
5 Feb 2026Brand Name: STA Liatest D-Di Product Name: STA Liatest D-Di Model/Catalog Number: REF 00515 Product Description: in vitrDeviceClass II1
4 Feb 2026Brand Name: STA Liatest Free Protein S Product Name: STA Liatest Free Protein S Model/Catalog Number (REF): 00516 ProducDeviceClass II1
15 Dec 2025Asserachrom HPIA. Model/Catalog Number: 00615. The Asserachrom HPIA kit is intended for the qualitative detection in plaDeviceClass II1
12 Sep 2025Product: STA Liatest D-Di; REF: 00515;DeviceClass II1
21 Jul 2025STA Satellite. Product Code: All references. All software versions. The STA Satellite is a fully automated benchtop analDeviceClass II4
21 May 2025STA - Owren Koller. Model/Catalog Number: 00360 STA - Owren-Koller is a buffer solution intended for use as a diluent foDeviceClass II1
4 Mar 2020STA - Deficient VIII, Product Code: 00725. STA - Deficient VIII is an immuno-depleted human plasma intended for use in tDeviceClass II1
18 Nov 2019STA UNICALIBRATOR (ref. 00675)DeviceClass II2
14 Nov 2018Staclot¿ LA (REF 00600) The Staclot¿ LA and Staclot¿ LA 20 test kits are reagent systems designed for the qualitative deDeviceClass II2

All 16 events for Diagnostica Stago, Inc.

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "An internal investigation identified a bug in this firmware version, resulting in the following:Intermittent shortened coagulation times and an increased frequency of occurrence of a technical error reported by the analyzer (error 13)."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "US Nationwide distribution in the states of IL, MA, MN, NE, TX, and WI."

Is the recall still ongoing?

FDA lists the status as Ongoing. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.